{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:40:53Z","timestamp":1791812453445,"version":"4.3.4"},"reference-count":66,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.18632\/aging.205977","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:30:01Z","timestamp":1719675001000},"page":"11224-11247","source":"Crossref","is-referenced-by-count":2,"title":["Pan-cancer analysis of T-cell proliferation regulatory genes as potential immunotherapeutic targets"],"prefix":"10.18632","volume":"16","author":[{"given":"Ruqiong","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Orthopedic and Trauma Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Cardiovascular Hospital of Kunming Medical University (Fuwai Yunnan Cardiovascular Hospital), Kunming, Yunnan 650000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, Guangxi 537100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eca del Mar Requena","family":"Mullor","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Almer\u00eca, Carretera de Sacramento, Almeria 04120, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Alarc\u00f2n","family":"Rodr\u00ecguez","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Almer\u00eca, Carretera de Sacramento, Almeria 04120, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Orthopedic and Trauma Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinteng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic and Trauma Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental Relationships of Four Exhausted CD8T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.","volume":"5","author":"Xu","year":"2020","journal-title":"Immunity"},{"key":"2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle.","volume":"3","author":"Mellman","year":"2013","journal-title":"Immunity"},{"key":"3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.","volume":"1","author":"Guan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/d41586-017-07267-9","article-title":"How T cells spot tumour cells.","volume":"55","author":"Hacohen","year":"2017","journal-title":"Nature"},{"key":"5","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.","volume":"18","author":"Billingsley","year":"2021","journal-title":"Cell"},{"key":"6","doi-asserted-by":"publisher","first-page":"e003100","DOI":"10.1136\/jitc-2021-003100","article-title":"CXCR6 is required for antitumor efficacy of intratumoral CD8T cell.","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","article-title":"Not-so-opposite ends of the spectrum: CD8T cell dysfunction across chronic infection, cancer and autoimmunity.","volume":"2","author":"Sharpe","year":"2021","journal-title":"Nat Immunol"},{"key":"8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion.","volume":"1","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion.","volume":"2","author":"Ho","year":"2020","journal-title":"Nat Metab"},{"key":"10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40425-016-0109-1","article-title":"Metabolic communication in tumors: a new layer of immunoregulation for immune evasion.","volume":"4","author":"Liu","year":"2016","journal-title":"J Immunother Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.4049\/jimmunol.1002650","article-title":"Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.","volume":"18","author":"Broxmeyer","year":"2011","journal-title":"J Immunol"},{"key":"12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.","volume":"1","author":"Ho","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10and IL-35Tcells cooperatively promotes tumor T cell exhaustion.","volume":"2","author":"Luketich","year":"2019","journal-title":"Nat Immunol"},{"key":"14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: characteristics, causes and conversion.","volume":"12","author":"Zajac","year":"2010","journal-title":"Immunology"},{"key":"15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.","volume":"31","author":"Cugnenc","year":"2006","journal-title":"Science"},{"key":"16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/cancers12051076","article-title":"Tumor-Infiltrating CD8 T Cells Predict Clinical Breast Cancer Outcomes in Young Women.","volume":"1","author":"Hu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"17","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.","volume":"10","author":"Sato","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2018.79.2648","article-title":"The Immunobiology of Kidney Cancer.","volume":"3","author":"Stein","year":"2018","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.","volume":"1","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"e002591","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.","volume":"9","author":"Koyama","year":"2021","journal-title":"J Immunother Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"e004037","DOI":"10.1136\/jitc-2021-004037","article-title":"Gallic acid induces T-helper-1-like Tcells and strengthens immune checkpoint blockade efficacy.","volume":"1","author":"Li","year":"2022","journal-title":"J Immunother Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.abj8695","article-title":"TCR-V\u03b3\u03b4 usage distinguishes protumor from antitumor intestinal \u03b3\u03b4 T cell subsets.","volume":"37","author":"Bortolatto","year":"2022","journal-title":"Science"},{"key":"23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"14","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"24","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1038\/s41467-022-31055-3","article-title":"Recurrent somatic mutations as predictors of immunotherapy response.","volume":"1","author":"Sanjana","year":"2022","journal-title":"Nat Commun"},{"key":"25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri2526","article-title":"The role of TNF superfamily members in T-cell function and diseases.","volume":"9","author":"Croft","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2016.08.004","article-title":"T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.","volume":"3","author":"Runza","year":"2016","journal-title":"Cancer Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2018.05.012","article-title":"Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-\u03b1-Dependent Intensification of Oxidative Stress and Tumor Cell Death.","volume":"2","author":"Blazar","year":"2018","journal-title":"Cell Metab"},{"key":"28","doi-asserted-by":"publisher","first-page":"eaar3451","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor immune evasion arises through loss of TNF sensitivity.","volume":"3","author":"Voskoboinik","year":"2018","journal-title":"Sci Immunol"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5MIR0917-351R","article-title":"IFN-\u03b3 orchestrates tumor elimination, tumor dormancy, tumor escape, and progression.","author":"Manjili","year":"2018","journal-title":"J Leukoc Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8T Cell-Derived Interferon-\u03b3.","volume":"5","author":"Delgoffe","year":"2019","journal-title":"Immunity"},{"key":"31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41467-017-00925-6","article-title":"Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.","volume":"8","author":"van der Bruggen","year":"2017","journal-title":"Nat Commun"},{"key":"32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/2159-8290.CD-21-1022","article-title":"IFN\u03b1 Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.","volume":"1","author":"Yang","year":"2022","journal-title":"Cancer Discov"},{"key":"33","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1038\/s41467-018-06890-y","article-title":"Targeting IFN\u03b1 to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.","volume":"9","author":"Dong","year":"2018","journal-title":"Nat Commun"},{"key":"34","doi-asserted-by":"publisher","first-page":"10554","DOI":"10.1038\/ncomms10554","article-title":"NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.","volume":"7","author":"Guarda","year":"2016","journal-title":"Nat Commun"},{"key":"35","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1084\/jem.20182124","article-title":"Specific targeting of CD163TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.","volume":"21","author":"Lawrence","year":"2019","journal-title":"J Exp Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer.","volume":"1","author":"Grandis","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","article-title":"The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer.","volume":"4","author":"Huang","year":"2016","journal-title":"Int J Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2018.10.010","article-title":"Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.","volume":"4","author":"Chi","year":"2018","journal-title":"Immunity"},{"key":"39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8T cell exhaustion by activating the aryl hydrocarbon receptor.","volume":"2","author":"Xie","year":"2021","journal-title":"Nat Immunol"},{"key":"40","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.3390\/ijms22115955","article-title":"Inactivation of the Akt\/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells.","volume":"2","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neo.2021.12.002","article-title":"Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer.","volume":"2","author":"Khabele","year":"2022","journal-title":"Neoplasia"},{"key":"42","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1158\/1078-0432.CCR-21-1141","article-title":"A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.","volume":"2","author":"Johnstone","year":"2021","journal-title":"Clin Cancer Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2014.59.2782","article-title":"Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.","volume":"3","author":"Walewski","year":"2015","journal-title":"J Clin Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3324\/haematol.2010.031633","article-title":"Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival.","volume":"9","author":"Poggi","year":"2011","journal-title":"Haematologica"},{"key":"45","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/s41467-021-22407-6","article-title":"Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy.","volume":"1","author":"Shen","year":"2021","journal-title":"Nat Commun"},{"key":"46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/0008-5472.CAN-13-1545","article-title":"Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.","volume":"7","author":"Larmonier","year":"2014","journal-title":"Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1021\/acs.analchem.8b05616","article-title":"Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.","volume":"9","author":"Gujar","year":"2019","journal-title":"Anal Chem"},{"key":"48","doi-asserted-by":"publisher","first-page":"110377","DOI":"10.1016\/j.biopha.2020.110377","article-title":"Chemo-immunotherapy with doxorubicin prodrug and erythrocyte membrane-enveloped polymer nano-vaccine enhances antitumor activity.","volume":"12","author":"Fu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1476-4598-13-34","article-title":"CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.","volume":"1","author":"Li","year":"2014","journal-title":"Mol Cancer"},{"key":"50","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/ijc.28163","article-title":"Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling.","volume":"13","author":"Lundqvist","year":"2013","journal-title":"Int J Cancer"},{"key":"51","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/eji.201242505","article-title":"Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.","volume":"4","author":"Sexl","year":"2013","journal-title":"Eur J Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1474-9726.2012.00819.x","article-title":"Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8T cells sensitizing them to apoptotic cell death.","volume":"1","author":"Grubeck-Loebenstein","year":"2012","journal-title":"Aging Cell"},{"key":"53","doi-asserted-by":"publisher","first-page":"4102666","DOI":"10.1155\/2022\/4102666","article-title":"Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.","volume":"202","author":"Fu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"54","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.","volume":"12","author":"Chen","year":"2019","journal-title":"J Clin Invest"},{"key":"55","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fimmu.2018.00617","article-title":"Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2\/3 Expression.","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"56","doi-asserted-by":"publisher","first-page":"108632","DOI":"10.1016\/j.biopha.2019.108632","article-title":"Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.","volume":"11","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"57","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1158\/1078-0432.CCR-17-1201","article-title":"Increased IFN\u03b3T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy.","volume":"2","author":"Han","year":"2017","journal-title":"Clin Cancer Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41467-020-20696-x","article-title":"Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming.","volume":"1","author":"Dong","year":"2021","journal-title":"Nat Commun"},{"key":"59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13046-020-01741-5","article-title":"Evodiamine suppresses non-small cell lung cancer by elevating CD8T cells and downregulating the MUC1-C\/PD-L1 axis.","volume":"3","author":"Leung","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"60","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fimmu.2020.01172","article-title":"Piperlongumine Acts as an Immunosuppressant by Exerting Prooxidative Effects in Human T Cells Resulting in Diminished T17 but Enhanced TDifferentiation.","volume":"1","author":"Samstag","year":"2020","journal-title":"Front Immunol"},{"key":"61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jconrel.2020.04.040","article-title":"Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer.","volume":"32","author":"Huang","year":"2020","journal-title":"J Control Release"},{"key":"62","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1021\/acsami.9b19148","article-title":"Ultrafast Low-Temperature Photothermal Therapy Activates Autophagy and Recovers Immunity for Efficient Antitumor Treatment.","volume":"1","author":"Shao","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"63","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04494-7","article-title":"A genome-scale screen for synthetic drivers of T cell proliferation.","volume":"60","author":"Sanjana","year":"2022","journal-title":"Nature"},{"key":"64","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"4","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"65","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to Pharmacometric Graphics.","volume":"2","author":"Murphy","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"66","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis.","volume":"3","author":"Guo","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:37:26Z","timestamp":1722879446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":66,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7,31]]}},"alternative-id":["205977","39068665"],"URL":"https:\/\/doi.org\/10.18632\/aging.205977","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}